Publications 2011

189.
Mullen W, Gonzalez J, Siwy J, Franke J, Sattar N, Mullan A, Roberts S, Delles C, Mischak H, Albalat A.
A Pilot Study on the Effect of Short-Term Consumption of a Polyphenol Rich Drink on Biomarkers of Coronary Artery Disease Defined by Urinary Proteomics
J Agric Food Chem. 2011, 59(24):12850-7
       
View Abstract     Request Reprint 

188.
Jahn H, Wittke S, Zürbig P, Raedler TJ, Arlt S, Kellmann M, Mullen W, Eichenlaub M, Mischak H, Wiedemann K
Peptide fingerprinting of Alzheimer´s disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers
PLoS ONE 2011, 6(10): e26540
         
View Abstract     Request Reprint 

187.
Albalat A, Mischak H, Mullen W.
Clinical application of urinary proteomics/peptidomics
Expert Rev Proteomics 2011, 8(5):615-29.
         
View Abstract     Request Reprint 

186.
Mullen W, Delles C, Mischak H; members of EuroKUP COST action.
Urinary proteomics in the assessment of chronic kidney disease
Curr Opin Nephrol Hypertens. 2011, 20(6):654-61.
         
View Abstract     Request Reprint 

185.
Mischak H, Thongboonkerd V, Schanstra JP, Vlahou A
Renal and urinary proteomics
Proteomics Clin Appl. 2011, 5(5-6):211-3.
         
View Abstract     Request Reprint 

184.
Albalat A, Mischak H, Mullen W
Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation
Prilozi. 2011, 32(1):13-44.
         
View Abstract     Request Reprint 

183.

Frantzi M, Bitsika V, Charonis A, Vlahou A.

Proteomics approaches in the quest of kidney disease biomarkers

Prilozi. 2011, 32(2):33-51.

View Abstract     Request Reprint 

182.
Kistler AD, Siwy J, Breunig F, Jeevaratnam P, Scherl A, Mullen W, Warnock DG, Wanner C, Hughes DA, Mischak H, Wüthrich RP, Serra AL
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to Enzyme Replacement Therapy
PLoS One. 2011, 6(6):e20534. Epub 2011 Jun 15.
         
View Abstract     Request Reprint 

181.
Zürbig P, Dihazi H, Metzger J, Thongboonkerd V, Vlahou A
Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications
Proteomics Clin Appl. 2011, 5(5-6):256-68.

View Abstract     Request Reprint 

180.
Siwy J, Mullen W, Golovko I, Franke J, Zürbig P
Human urinary peptide database for multiple disease biomarker discovery
Proteomics Clin Appl. 2011, 5(5-6):367-74.
         
View Abstract     Request Reprint 

179.
Metzger J, Chatzikyrkou C, Broecker V, Schiffer E, Jaensch L, Iphoefer A, Mengel M, Mullen W, Mischak H, Haller H, Gwinner W
Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis
Proteomics Clin Appl. 2011, 5(5-6):322-33.
         
View Abstract     Request Reprint 

178.
Schiffer E, Liabeuf S, Lacroix C, Temmar M, Renard C, Monsarrat B, Choukroun G, Lemke HD, Vanholder R, Mischak H, Massy ZA; on behalf of the European Uremic Toxin Work Group (EUTox).
Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis
J Hypertens. 2011, 29(4):783-790.
         
View Abstract     Request Reprint 

177.
Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W, Franke J, McCulloch JW, North RA, Chappell LC, Mischak H, Poston L, Dominiczak AF, Delles C.
Urinary Proteomics for Prediction of Preeclampsia
Hypertension. 2011, 57(3):561-9.
         
View Abstract     Request Reprint 

176.
Ehrich JH, Schiffer E, Drube J.
Urinary proteomics : The diagnostic key for urinary tract abnormalities and kidney diseases in children?
Urologe A. 2011, 50(2):170-179.
         
View Abstract     Request Reprint 

175.
Mayer G, Heinze G, Mischak H, Hellemons ME, Heerspink HJ, Bakker SJ, de Zeeuw D, Haiduk M, Rossing P, Oberbauer R
Omics-bioinformatics in the context of clinical data
Methods Mol Biol. 2011, 719:479-97.
         
View Abstract     Request Reprint 

174.

Lopez LM, Mullen W, Zürbig P, Harris SE, Gow AJ, Starr JM, Porteous DJ, Mischak H, Deary IJ.
A pilot study of urinary peptides as biomarkers for intelligence in old age.
Intelligence 2011, 39(1):46–53.

View Abstract     Request Reprint 

173.

Liabeuf S, Schiffer E, Lacroix C, Temmar M, Renard C, Monsarrat B, Choukroun G, Lemke HD, Vanholder R, Mischak H, Massy ZA.
Marqueurs de la maladie vasculaire identifiés par analyse de protéomique dans le sérum de patients avec une maladie rénale chronique
Néphrologie & Thérapeutique 2011, 7(5):275–276.

View Abstract     Request Reprint 

172.
Mischak H, Schanstra JP.
CE-MS in biomarker discovery, validation, and clinical application
Proteomics Clin Appl. 2011, 5(1-2):9-23.
         
View Abstract     Request Reprint 

171.
Schiffer E.
Urinary proteomics: ready for prime time in urological cancer diagnostics?
Personalized Medicine 2011, Jan;8 (1): 81-94.
         
View Abstract     Request Reprint 

170.
Siwy J, Vlahou A, Zimmerli LU, Zürbig P, Schiffer E
Clinical proteomics: Current techniques and potential applications in the elderly
Maturitas. 2011, 68(3):233-44
         
View Abstract     Request Reprint 

169.
Foucher C, Schiffer E, Mischak H, Ansquer JC, Wilbraham D
Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers
Proteomics Clin Appl. 2011, 5(3-4):159-66.
         
View Abstract     Request Reprint 

168.
Lankisch TO, Metzger J, Negm AA, Voßkuhl K, Schiffer E, Siwy J, Weismüller TJ, Andrea S. Schneider AS, Thedieck K, Baumeister R, Zuerbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis
Hepatology. 2011, 53(3):875-884.
         
View Abstract     Request Reprint